Evidence map›Paper›PMID 38293112›Full record

ArticlebioRxiv : the preprint server for biology2024

Zara Y Weinberg, Sarah S Soliman, Matthew S Kim, Devan H Shah, Irene P Chen, Melanie Ott, Wendell A Lim, Hana El-Samad

Open access · greenAbstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Zara Y WeinbergDepartment of Biochemistry & Biophysics, UCSF, San Francisco CA.ORCID 0000-0001-7176-038X
Sarah S SolimanDepartment of Biochemistry & Biophysics, UCSF, San Francisco CA.ORCID 0009-0003-8918-3332
Matthew S KimTetrad Gradudate Program, UCSF, San Francisco CA.ORCID 0000-0002-5836-8874
Devan H ShahUC Berkeley-UCSF Graduate Program in Bioengineering, University of California, Berkeley, CA.ORCID 0009-0002-4081-4642
Irene P ChenGladstone Institutes, San Francisco CA.ORCID 0000-0002-5766-9253
Melanie OttGladstone Institutes, San Francisco CA.ORCID 0000-0002-5697-1274
Wendell A LimCell Design Institute, San Francisco CA.ORCID 0000-0003-4052-8056
Hana El-SamadDepartment of Biochemistry & Biophysics, UCSF, San Francisco CA.ORCID 0000-0001-6239-9916
San Francisco Art Institute · USGladstone Institutes · USUniversity of California, San Francisco · USUniversity of California, Berkeley · US

Funding

UCSF IRACDA Scholars ProgramK12GM081266 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Raymond M. Esquerra, HOLLY A. INGRAHAM · 2007 to 2026
$19.4M
Understanding and rewiring cellular behavior with synthetic biology approachesK99GM147825 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI WEINBERG, ZARA · 2023 to 2024
$250k
Suppression of Host Antiviral Responses by a SARS-CoV-2 Histone MimeticF31AI164671 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI CHEN, IRENE PO-RU · 2021 to 2022
$82k
NIAID NIH HHS F31 AI164671NIGMS NIH HHS K12 GM081266NIGMS NIH HHS K99 GM147825
6 · The paper itself

Abstract

Synthetic and chimeric receptors capable of recognizing and responding to user-defined antigens have enabled "smart" therapeutics based on engineered cells. These cell engineering tools depend on antigen sensors which are most often derived from antibodies. Advances in the

Identifiers

PMID38293112
PMCPMC10827046
OpenAlexW4390871566

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.